Download PDF
J Neurol Surg B Skull Base 2024; 85(06): 614-621
DOI: 10.1055/s-0043-1775753
Original Article

Neurocognitive Functioning of Patients with Sinonasal and Nasopharyngeal Cancers Treated With Multimodality Therapy

Dan Yaniv 
1   Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Lindsay M. Niccolai
2   Department of Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Jeffrey S. Wefel
2   Department of Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
3   Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Catherine M. Sullaway
2   Department of Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Jack Phan
3   Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Clifton David Fuller
3   Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Kareem B. Haroun
4   Department of Otolaryngology, The University of Texas Medical Branch, Galveston, Texas, United States
,
Ehab Y. Hanna
1   Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Shirley Y. Su
1   Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Importance Few recent studies have examined neurocognitive functioning (NCF) in patients with sinonasal and nasopharyngeal cancers (NPCs) prior to and following multimodality therapy or the potential differences in NCF by disease variables such as disease site.

Objective The objective of this study is to determine rates of NCF impairments prior to and following multimodality therapy, declines in NCF following radiotherapy (RT), and possible differences in NCF by the disease site.

Design, Setting, and Participants We conducted a retrospective chart review of 39 patients with sinonasal and NPCs who underwent comprehensive neuropsychological evaluations. Twenty patients were evaluated prior to RT, of which eleven received follow-up evaluation after completion of RT. Nineteen patients were evaluated following various treatments without a pre-RT evaluation.

Main Outcomes and Measures Patients completed comprehensive neuropsychological evaluations. Decline from pre-RT to follow-up was defined on the basis of reliable change indices.

Results Thirty-nine patients completed comprehensive neuropsychological evaluations. For the entire cohort, the most frequently demonstrated impairments were in verbal memory (47%) and learning (43%), executive functioning (33%), and verbal fluency (22%). At post-RT follow-up, the most frequently observed declines were in verbal learning (46%) and memory (18%). Demographic and disease variables were not significantly associated with NCF at pre-RT or post-RT.

Conclusion and Relevance Patients with sinonasal and NPCs are at risk for NCF impairments in multiple areas at baseline and memory decline following RT. Future prospective studies are needed to investigate the impact of each treatment modality on NCF and specific risk factors for cognitive dysfunction.

Keywords

executive functioning - radiotherapy - cognitive impairment - chemotherapy


Publication History

Received: 19 January 2023

Accepted: 27 August 2023

Article published online:
27 September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Cheung M-C, Chan AS, Law SC, Chan JH, Tse VK. Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma. Cancer 2003; 97 (08) 2019-2026
    CrossrefPubMedGoogle Scholar
  • 2 Cheung M, Chan AS, Law SC, Chan JH, Tse VK. Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis. Arch Neurol 2000; 57 (09) 1347-1352
    CrossrefPubMedGoogle Scholar
  • 3 Hsiao KY, Yeh SA, Chang CC, Tsai PC, Wu JM, Gau JS. Cognitive function before and after intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2010; 77 (03) 722-726
    CrossrefPubMedGoogle Scholar
  • 4 Hua M-S, Chen S-T, Tang L-M, Leung W-M. Neuropsychological function in patients with nasopharyngeal carcinoma after radiotherapy. J Clin Exp Neuropsychol 1998; 20 (05) 684-693
    CrossrefPubMedGoogle Scholar
  • 5 Lam LCW, Leung SF, Chan YL. Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma. J Neuropsychiatry Clin Neurosci 2003; 15 (01) 90-97
    CrossrefPubMedGoogle Scholar
  • 6 Lee PW, Hung BK, Woo EK, Tai PT, Choi DT. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry 1989; 52 (04) 488-492
    CrossrefPubMedGoogle Scholar
  • 7 Fuller CD, Schillerstrom JE, Jones III WE, Boersma M, Royall DR, Fuss M. Prospective evaluation of pretreatment executive cognitive impairment and depression in patients referred for radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72 (02) 529-533
    CrossrefPubMedGoogle Scholar
  • 8 Ahles TA, Saykin AJ, McDonald BC. et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2008; 110 (01) 143-152
    CrossrefPubMedGoogle Scholar
  • 9 Schagen SB, Klein M, Reijneveld JC. et al. Monitoring and optimising cognitive function in cancer patients: present knowledge and future directions. Eur J Cancer, Suppl 2014; 12 (01) 29-40
    CrossrefPubMedGoogle Scholar
  • 10 Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer 2004; 101 (03) 466-475
    CrossrefPubMedGoogle Scholar
  • 11 Bond SM, Dietrich MS, Murphy BA. Neurocognitive function in head and neck cancer patients prior to treatment. Support Care Cancer 2012; 20 (01) 149-157
    CrossrefPubMedGoogle Scholar
  • 12 Piai V, Prins JB, Verdonck-de Leeuw IM. et al. Assessment of neurocognitive impairment and speech functioning before head and neck cancer treatment. JAMA Otolaryngol Head Neck Surg 2019; 145 (03) 251-257
    CrossrefPubMedGoogle Scholar
  • 13 Sinha P, Wong AWK, Kallogjeri D, Piccirillo JF. Baseline cognition assessment among patients with oropharyngeal cancer using PROMIS and NIH Toolbox. JAMA Otolaryngol Head Neck Surg 2018; 144 (11) 978-987
    CrossrefPubMedGoogle Scholar
  • 14 Zygogianni A, Kyrgias G, Mystakidou K. et al. Potential role of the alcohol and smoking in the squamous cell carcinoma of the head and neck: review of the current literature and new perspectives. Asian Pac J Cancer Prev 2011; 12 (02) 339-344
    PubMedGoogle Scholar
  • 15 Abayomi OK. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol 2002; 41 (04) 346-351
    CrossrefPubMedGoogle Scholar
  • 16 Cross NE, Glantz MJ. Neurologic complications of radiation therapy. Neurol Clin 2003; 21 (01) 249-277
    CrossrefPubMedGoogle Scholar
  • 17 Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 2003; 42 (5–6): 443-461
    CrossrefPubMedGoogle Scholar
  • 18 Meyers CA, Geara F, Wong P-F, Morrison WH. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys 2000; 46 (01) 51-55
    CrossrefPubMedGoogle Scholar
  • 19 Hansen CC, Smith JB, Mohamed ASR. et al; MD Anderson Head and Neck Cancer Symptom Working Group. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: a cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck 2017; 39 (10) 2048-2056
    CrossrefPubMedGoogle Scholar
  • 20 Gan HK, Bernstein LJ, Brown J. et al. Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011; 81 (01) 126-134
    CrossrefPubMedGoogle Scholar
  • 21 Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 2008; 7 (04) 12
    CrossrefPubMedGoogle Scholar
  • 22 Troy L, McFarland K, Littman-Power S. et al. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology 2000; 9 (01) 29-39
    CrossrefPubMedGoogle Scholar
  • 23 Jonson R, Börjesson J, Mattsson S, Unsgaard B, Wallgren A. Uptake and retention of platinum in patients undergoing cisplatin therapy. Acta Oncol 1991; 30 (03) 315-319
    CrossrefPubMedGoogle Scholar
  • 24 Welsh LC, Dunlop AW, McGovern T. et al. Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin Oncol (R Coll Radiol) 2014; 26 (12) 765-775
    CrossrefPubMedGoogle Scholar
  • 25 Zer A. et al. Association of neurocognitive deficits with radiotherapy or chemoradiotherapy for patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg 2017; 144 (01) 71-79
    PubMedGoogle Scholar
  • 26 Benedict RHB, Lutz F. Brief Visuospatial Memory Test—Revised: Professional Manual. Psychological Assessment Resources, Inc.; 1997
    Google Scholar
  • 27 Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test – revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 1998; 12: 43-55
    CrossrefPubMedGoogle Scholar
  • 28 Benton A, Hamsher K, Sivan A. Multilingual Aphasia Examination Manual. AJA Associates Inc.; 2000
    Google Scholar
  • 29 Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. 2004
    PubMedGoogle Scholar
  • 30 Ruff RM, Light RH, Parker SB, Levin HS. Benton controlled oral word association test: Reliability and updated norms. Arch Clin Neuropsychol 1996; 11 (04) 329-338
    CrossrefPubMedGoogle Scholar
  • 31 Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004; 19 (02) 203-214
    CrossrefPubMedGoogle Scholar
  • 32 Wechsler D. Wechsler Adult Intelligence Scale-IV. The Psychological Corporation; 2008
    Google Scholar
  • 33 Wechsler D. Wechsler Adult Intelligence Scale-III. The Psychological Corporation; 1997
    Google Scholar
  • 34 Bond SM, Dietrich MS, Gilbert J, Ely EW, Jackson JC, Murphy BA. Neurocognitive function in patients with head and neck cancer undergoing primary or adjuvant chemoradiation treatment. Support Care Cancer 2016; 24 (10) 4433-4442
    CrossrefPubMedGoogle Scholar
  • 35 Gibson E, Monje M. Effect of cancer therapy on neural stem cells: implications for cognitive function. Curr Opin Oncol 2012; 24 (06) 672-678
    CrossrefPubMedGoogle Scholar
  • 36 Brown PD, Pugh S, Laack NN. et al; Radiation Therapy Oncology Group (RTOG). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncol 2013; 15 (10) 1429-1437
    CrossrefPubMedGoogle Scholar
  • 37 Gondi V, Pugh SL, Tome WA. et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 2014; 32 (34) 3810-3816
    CrossrefPubMedGoogle Scholar
  • 38 Dunlop A, Welsh L, McQuaid D. et al. Brain-sparing methods for IMRT of head and neck cancer. PLoS One 2015; 10 (03) e0120141
    CrossrefPubMedGoogle Scholar
  • 39 Dye NB, Gondi V, Mehta MP. Strategies for preservation of memory function in patients with brain metastases. Chin Clin Oncol 2015; 4 (02) 24-24
    PubMedGoogle Scholar